Global Plasma Fractionation Market

Report ID : 1262 | Published : 2022-06-14 | Pages: | Format: PDF/EXCEL

The Global Plasma Fractionation Market is estimated to reach over USD 40.45 billion by 2030, exhibiting a CAGR of 7.6% during the forecast period. 

Plasma fractionation is the extraction of multiple parts of plasma, a component of blood acquired through blood fractionation. Plasma can be separated and used for a variety of medicinal purposes. The growing awareness of regular check-ups and follow-up check-ups has pushed plasma fractionation forward. The rise in demand is attributable to an increase in respiratory disorders among people of all ages, particularly among the elderly. As a result, the need for plasma collecting centers has skyrocketed. The increased use of immunoglobulins and alpha-1-antitrypsin in medical fields worldwide is propelling the plasma fractionation market forward.

Furthermore, increasing plasma collecting facilities worldwide is a crucial driver driving the market forward. Growing R&D efforts, government initiatives to use sustainable components for production, and investments by significant players are likely to generate lucrative revenue prospects for players operating in the global plasma fractionation market. Besides, strict government regulations and a reduction in plasma supply due to the low don or turnout are expected to limit market growth to a certain degree throughout the forecast period. Also, favorable government assistance for raising knowledge about the utilization of plasma-derived products is propelling the plasma fractionation market forward. However, the high cost of plasma-derived goods limits the market expansion over the upcoming years. However, emerging economies' growth potential is expected to generate profitable prospects for market growth over the forthcoming years.

Market Segmentation:

The plasma fractionation market is segmented based on products, applications, and end-users. Based on product, the market is segmented as Instruments, Coagulation Factors, Albumin, Protease Inhibitors and Other Products. By application, the market is segmented into Immunology, Hematology, Neurology Critical Care, Haemato-Oncology, Rheumatology and Other Applications. Based on end-users, the market is segmented into hospitals, Clinical Research labs, and Academic Institutes.

Based on application, the Immunology segment is accounted as a significant contributor to the plasma fractionation market.

The Immunology category is expected to hold a major share in the global plasma fractionation market in 2021. Increasing use of immunoglobulins for various indications such as primary or chronic immune deficiency, growing demand for illness treatment, and their benefits in improving diagnostic rates fuel the expansion of this segment. Immunoglobulin use is expected to rise as the prevalence of infections and illnesses rises in the coming years. Furthermore, an increase in immunology research across the globe is another significant contributor to the immunoglobulin market's rise.

Hospitals & clinics segment witness growth at a rapid rate

The Hospitals & clinics segment is projected to grow at a rapid rate in the global plasma fractionation market. Some of the major factors driving the growth of this segment are the growing need for therapies for immunodeficiency disorders, the increasing number of hospitals and healthcare expenditure, and the highest consumption of plasma-derived products by hospitals and clinics for therapies compared to others. Hospitals are expanding rapidly, fueled by joint ventures, acquisitions, and the provision of one-stop-shop services for a variety of medical requirements under one roof, especially in countries such as the US, Germany, UK, China, and India.

Asia-Pacific delivers significant potential for key players working in the plasma fractionation market

The Asia Pacific plasma fractionation market is expected to register the highest market share in terms of revenue soon. The presence of governmental bodies that regulate and supervise plasma collection, fractionation, and sales is a crucial element driving market expansion. Furthermore, rising rates of medical diseases such as severe fever with thrombocytopenia syndrome (SFTS), hemophilia, and primary and secondary immunological deficiencies propel the market forward. Other factors driving market growth include:

  • An increase in the ageing population.
  • Increased government assistance through Medicaid and healthcare regulations.
  • Advances in the healthcare infrastructure.

Furthermore, leading manufacturers' increased attention on extending their geographical presence in emerging North America to capture high market share is expected to fuel the region's plasma fractionation market expansion.

Competitive Landscape

The key players in the plasma fractionation market have shifted their focus towards bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the plasma fractionation market are CSL Limited, Grifols, S.A., Octa pharma AG, Sequin Blood Supply Foundation, and Takeda Pharmaceutical Company Limited.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Plasma Fractionation Market Snapshot

Chapter 4. Global Plasma Fractionation Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Market Share Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. COVID 19 Impact Analysis

Chapter 5. Market Segmentation 1: By Products, Estimates & Trend Analysis

5.1. By Products, & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Products:

5.2.1. Immunoglobulins

5.2.1.1.  Intravenous Immunoglobulins

5.2.1.2.  Subcutaneous Immunoglobulins

5.2.1.3.  Others

5.2.2. Coagulation Factors

5.2.3. Albumin

5.2.4. Protease Inhibitors

5.2.5. Other Products

Chapter 6. Market Segmentation 2: By Applications Estimates & Trend Analysis

6.1. By Applications & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Applications:

6.2.1. Immunology

6.2.2. Hematology

6.2.3. Neurology

6.2.4. Critical Care

6.2.5. Hemato-Oncology

6.2.6. Rheumatology

6.2.7. Other Applications

Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users & Market Share, 2019 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-Users:

7.2.1. Hospitals& Clinics

7.2.2. Clinical Research Laboratories

7.2.3. Academic Institutes

Chapter 8. Plasma Fractionation Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Products, 2019 - 2030

8.1.2. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Applications, 2019 - 2030

8.1.3. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By End-Users, 2019 - 2030

8.1.4. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts by country, 2019 - 2030

8.2. Europe

8.2.1. Europe Plasma Fractionation Market revenue (US$ Million) By Products, 2019 - 2030

8.2.2. Europe Plasma Fractionation Market revenue (US$ Million) By Applications, 2019 - 2030

8.2.3. Europe Plasma Fractionation Market revenue (US$ Million) By End-Users, 2019 - 2030

8.2.4. Europe Plasma Fractionation Market revenue (US$ Million) by country, 2019 - 2030

8.3. Asia Pacific

8.3.1. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Products, 2019 - 2030

8.3.2. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Applications, 2019 - 2030

8.3.3. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By End-Users, 2019 - 2030

8.3.4. Asia Pacific Plasma Fractionation Market revenue (US$ Million) by country, 2019 - 2030

8.4. Latin America

8.4.1. Latin America Plasma Fractionation Market revenue (US$ Million) By Products, (US$ Million)

8.4.2. Latin America Plasma Fractionation Market revenue (US$ Million) By Applications, (US$ Million)

8.4.3. Latin America Plasma Fractionation Market revenue (US$ Million) By End-Users, (US$ Million)

8.4.4. Latin America Plasma Fractionation Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Products, (US$ Million)

8.5.2. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Applications, (US$ Million)

8.5.3. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By End-Users, (US$ Million)

8.5.4. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. CSL Limited

9.2.2. Grifols, S.A.

9.2.3. Octapharma AG

9.2.4. Kedrion S.P.A.

9.2.5. Shire Plc (Subsidiary of Takeda Pharmaceutical Company Limited)

9.2.6. Biotest AG

9.2.7. China Biologic Products Holdings, Inc.

9.2.8. Bio Products Laboratory (BPL) Ltd

9.2.9. Japan Blood Products Organization

9.2.10. Shanghai RAAS Blood Products Co., Ltd.

9.2.11. Other Prominent Player

Segmentation of Plasma fractionation Market-

"By Products

  • Instruments
  • Coagulation Factors
  • Albumin
  • Protease Inhibitors
  • Other Products

By Applications

  • Immunology
  • Hematology
  • Neurology
  • Critical Care
  • Haemato-Oncology
  • Rheumatology
  • Other Applications

By End-Users

  • Hospitals& Clinics
  • Clinical Research Laboratories
  • Academic Institutes"

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients